| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/06/2002 | WO2001079442A3 Albumin fusion proteins |
| 06/06/2002 | WO2001074999A3 A novel polypeptide - short chain dehydrogenase/reductase 14 and the polynucleotide encoding said polypeptide |
| 06/06/2002 | WO2001074128A3 A novel polypeptide, microtubulin 11 and the polynucleotide encoding the polypeptide |
| 06/06/2002 | WO2001072784A3 Peptides binding to non-acetylated h3 and h4 histones for cancer therapy |
| 06/06/2002 | WO2001068643A3 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 06/06/2002 | WO2001068098A3 Cephalotaxine alkaloid combination compositions and uses thereof |
| 06/06/2002 | WO2001068071A3 Use of natural chrysanthone compounds having antiangiogenic activity |
| 06/06/2002 | WO2001064907A3 Lipid metabolism enzymes |
| 06/06/2002 | WO2001064884A3 G12l, a gene associated with the thermal response |
| 06/06/2002 | WO2001044207B1 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1,2,4]triazol, methods for producing them and pharmaceutical compositions containing them |
| 06/06/2002 | WO2001036645A3 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same |
| 06/06/2002 | WO2001012168A3 Antiviral pharmaceutical compositions containing iron chelators |
| 06/06/2002 | WO2000024782A3 Modified peptides, comprising an fc domain, as therapeutic agents |
| 06/06/2002 | US20020069422 Proteins for use in the treatment of trypanosome infection, cancer, inflammation and immunological defects |
| 06/06/2002 | US20020068756 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 06/06/2002 | US20020068755 Antitumor agents. |
| 06/06/2002 | US20020068753 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 06/06/2002 | US20020068746 Pyrrolo[2,3-d]pyrimidine compounds |
| 06/06/2002 | US20020068744 Interacting with tubulin and microtubules and promoting microtubule polymerization |
| 06/06/2002 | US20020068743 Composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer |
| 06/06/2002 | US20020068742 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 06/06/2002 | US20020068735 Progesterone receptor antagonist; inhibiting breast, uterine, ovarian, endometrial, or prostate cancer |
| 06/06/2002 | US20020068723 Altering the conformational equilibrium of the A- ring to favor a chair conformation that presents the 1 alpha-hydroxyl in the axial orientation. |
| 06/06/2002 | US20020068721 Purine derivatives |
| 06/06/2002 | US20020068716 Pituitary-tumor-transforming-gene (PTTG) polypeptide expressed by pituitary tumor cells, which binds anti-PTTG antibody. |
| 06/06/2002 | US20020068709 Modulating expression of a gene involved in malignant cell growth, comprising contacting with an oligonucleotide that comprises one or more locked nucleic acid units |
| 06/06/2002 | US20020068706 Inhibitors of cyclin-dependent kinases (CDKs), particularly CDK/cyclin complexes, can be used to control proliferation and/or differentiation of cells |
| 06/06/2002 | US20020068705 Sugar derivatives of indolocarbazoles; exhibit topoisomerase-I activity |
| 06/06/2002 | US20020068697 Peptides blocking vascular endothelial growth factor (VEGF) -mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof |
| 06/06/2002 | US20020068696 Modulating proliferation and apoptotic state of cells using agents that modulate the expression and/or activity of TRADE family polypeptides. |
| 06/06/2002 | US20020068694 Glycosylated VEGF-B and method for increasing the amount of soluble VEGF-B |
| 06/06/2002 | US20020068691 Breast specific gene or "BSGs" consisting of specific nucleotide sequences and proteins expressed by these gene; vaccine for prevention of breast cancer |
| 06/06/2002 | US20020068353 Nucleotide sequence coding tumor polypeptide for use as anticarcinogeneic agents |
| 06/06/2002 | US20020068341 Human kallikrein |
| 06/06/2002 | US20020068329 Fusion proteins for prodrug activation |
| 06/06/2002 | US20020068328 Liposomal pharmaceutical conjugate for use inthe treatment and diagnosis of tumors; antitumor agents; anticarcinogeneic agents |
| 06/06/2002 | US20020068319 32 human secreted proteins |
| 06/06/2002 | US20020068285 Compositions and methods for the therapy and diagnosis of breast cancer |
| 06/06/2002 | US20020068278 Protein for use as antitumor agent; for use as antimetastsis agent |
| 06/06/2002 | US20020068102 Use of dietary supplement includes juice from fruit of Morinda citrifolia to scavange lipid hydroperoxides and superoxide anion free radicals within the human body |
| 06/06/2002 | US20020068096 Antimonocytic activity of betel leaf extracts |
| 06/06/2002 | US20020068094 Physiologically active exract |
| 06/06/2002 | US20020068087 Bioadhesive hydrogels with functionalized degradable crosslinks |
| 06/06/2002 | US20020068061 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions |
| 06/06/2002 | US20020068053 Process for the production of anti-tumor Th1 cells |
| 06/06/2002 | US20020068047 Treating a wound with an invasion inducing agent such as peptides containing PHSRN sequence |
| 06/06/2002 | US20020068043 Fusion protein, comprising a receptor-antagonizing domain (such as prolactin receptor antagonist) and a positive immunomodulator domain (such as an interleukin); combines apoptosis induction and immunotherapy |
| 06/06/2002 | US20020067472 Such as 1,15-di(cyclopropylmethylamino)-8-benzyl-4,8,12-triazapentadecane; carcinostatic action |
| 06/06/2002 | EP1144454A3 Modified peptides as therapeutic agents |
| 06/06/2002 | DE10060388A1 Verwendung von Pyrazolo [4,3-d]pyrimidinen Use of pyrazolo [4,3-d] pyrimidines |
| 06/06/2002 | DE10060140A1 Multimerer mehrfach-antigenbindender einzelkettiger Antikörper Multimeric multiple antigen-binding single chain antibody |
| 06/06/2002 | DE10059630A1 Arzneimittel zur Vermeidung oder Behandlung von durch humanen Papillomavirus-Typ 18-hervorgerufenem Tumor Medicines used to prevent or treat by human papillomavirus type 18-evoked tumor |
| 06/06/2002 | DE10058596A1 Verfahren zum Screening von chemischen Verbindungen zur Modulierung der Wechselwirkung einer EVH1-Domäne oder eines Proteins mit einer EVH1-Domäne mit einer EVH1-Bindedomäne oder einem Protein mit einer EVH1-Bindedomäne sowie ein Verfahren zum Nachweis besagter Wechselwirkung Method for screening chemical compounds for modulating the interaction of an EVH1 domain or a protein having an EVH1 domain with an EVH1-binding domain or a protein having an EVH1-binding domain and a method for the detection of said interaction |
| 06/06/2002 | DE10055285A1 Neue Marker für die Diagnose und Therapie von Tumoren New marker for the diagnosis and therapy of tumors |
| 06/06/2002 | CA2791831A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2457925A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/06/2002 | CA2436348A1 Preparation of large liposomes by infusion into peg |
| 06/06/2002 | CA2431839A1 Conjugates of glycosylated/galactosylated peptide |
| 06/06/2002 | CA2431837A1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
| 06/06/2002 | CA2430625A1 A virus which can express tumor angiostatin factor with high efficiency in specific tumor cells and the use of it |
| 06/06/2002 | CA2430526A1 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy |
| 06/06/2002 | CA2430495A1 Oncolytic virus |
| 06/06/2002 | CA2430489A1 Methods for contemporaneous administration of levamisole and 5-fluorouracil |
| 06/06/2002 | CA2430485A1 Cytonkine receptor zcytor19 |
| 06/06/2002 | CA2430354A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | CA2430351A1 Human protooncogene and protein encoded therein |
| 06/06/2002 | CA2430334A1 Photochemical internalization for virus-mediated molecule delivery into the cyosol |
| 06/06/2002 | CA2430331A1 Human cervical cancer 2 protooncogene and protein encoded therein |
| 06/06/2002 | CA2430311A1 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | CA2430296A1 Anti-proliferative drugs |
| 06/06/2002 | CA2430257A1 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | CA2430239A1 A method of treating cancer |
| 06/06/2002 | CA2430087A1 Photochemical internalization for delivery of molecules into the cytosol |
| 06/06/2002 | CA2430077A1 Modified arginine deiminase |
| 06/06/2002 | CA2429987A1 Methods for the prevention and treatment of cancer using anti-c3b(i) antibodies |
| 06/06/2002 | CA2429814A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2429749A1 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | CA2429722A1 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | CA2429721A1 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 06/06/2002 | CA2429632A1 Neuropeptide y1 receptor binding compounds in the treatment and diagnosis of cancer |
| 06/06/2002 | CA2429599A1 Use of b7rp1 antagonists in ige-mediated disorders |
| 06/06/2002 | CA2429583A1 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 06/06/2002 | CA2429469A1 Human elongase genes and uses thereof |
| 06/06/2002 | CA2429382A1 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | CA2428018A1 Tetrapartate prodrugs |
| 06/05/2002 | EP1211311A2 Cord blood-derived activated lymphocytes and preparations containing said lymphocytes |
| 06/05/2002 | EP1211250A1 C10 taxane derivatives and pharmaceutical compositions |
| 06/05/2002 | EP1211240A1 Biscyclopropanecarboxylic acid amide compounds and medicinal use thereof |
| 06/05/2002 | EP1210605A2 Analysis and treatment of body weight and eating disorders |
| 06/05/2002 | EP1210463A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210462A2 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210454A1 Antisense modulation of shp-1 expression |
| 06/05/2002 | EP1210448A1 Recombinant hsv-1 and live viral vaccines |
| 06/05/2002 | EP1210447A2 Adenoviral vectors having nucleic acids encoding immunomodulatory molecules |
| 06/05/2002 | EP1210435A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 06/05/2002 | EP1210434A2 Mammalian interleukin-12 p40 and interleukin b30. combinations thereof. antibodies. uses in pharmaceutical compositions |
| 06/05/2002 | EP1210430A2 Muc-1 derived peptides |
| 06/05/2002 | EP1210429A2 Apoptosis proteins |
| 06/05/2002 | EP1210428A1 Pd-1, a receptor for b7-4, and uses therefor |
| 06/05/2002 | EP1210426A2 Polymorphisms in a klotho gene |